RxDoctor Payments DataLook up a doctor →

Peter Winkle

Gastroenterology · Cypress, CANPI 1992923460

Payments from drug & device makers

$116,702,737in general payments, 2019–2025

Across 1,487 payments — averaging $78,482 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$22.1M
  • Bristol Myers Squibb$17.2M
  • E.r. Squibb & Sons, L.L.C.$17M
  • AbbVie$14.2M
  • Amgen$14.1M
  • Janssen Research & Development, LLC$6.9M
  • plus $25.2M from 35 others
$785,412in research payments, 2019–2025

Across 17 payments — averaging $46,201 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Braintree Laboratories, Inc.$511K
  • Celltrion, Inc.$270K
  • Pfizer$4K

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer414$22,081,639
Bristol Myers Squibb12$17,150,833
E.r. Squibb & Sons, L.L.C.17$17,022,361
AbbVie(2 entities)309$14,214,162
Amgen29$14,067,147
Janssen Research & Development, LLC76$6,939,982
Eli Lilly17$5,715,109
Vertex15$4,548,146
Otsuka Pharmaceutical Co., Ltd.15$1,746,906
Idorsia Pharmaceuticals US Inc21$1,486,953
Genentech, Inc.6$1,106,485
Biogen2$1,012,879
Teva Pharmaceuticals USA, Inc.25$999,110
UCB SA1$934,495
GSK24$882,987
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)31$854,784
Acadia Pharmaceuticals Inc13$771,449
Merck6$755,861
Takeda Pharmaceuticals U.S.A., Inc.148$740,772
Upsher-smith Laboratories LLC52$711,747
Heron Therapeutics, Inc.13$631,089
Astrazeneca UK Limited3$578,751
Hikma Pharmaceuticals USA9$562,260
Sumitomo Pharma Co., Ltd.19$467,132
AstraZeneca3$297,523
Novavax Inc11$141,336
Novo Nordisk AS139$99,651
Braintree Laboratories, Inc.5$65,301
Ironwood Pharmaceuticals, Inc4$64,905
Mallinckrodt Enterprises LLC13$21,081
Mallinckrodt Hospital Products Inc.6$20,510
Novartis2$2,964
Mylan Specialty L.p.6$2,321
Sanofi-aventis U.S. LLC1$2,250
Biohaven Pharmaceuticals, Inc.2$1,561
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC11$177
Shionogi Inc3$55
Olympus America Inc.1$20
Gilead1$15
Johnson & Johnson1$15
W. L. Gore & Associates, Inc.1$11

How this compares

$116,702,737 in reported general payments places this provider in the 95th percentile of 1,885 gastroenterology providers in California.

See all gastroenterology providers in California →

Other gastroenterology in Cypress

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →